Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

420
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
420
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

490
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
490
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.5K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

3.3K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

568
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
568

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Discovery of MK-2118, a Small-Molecule Agonist of STING.

ACS medicinal chemistry letters·2026
Same author

Secondary consumption of mycorrhizal fungi by two endangered marsupial carnivores: the spotted-tailed quoll (Dasyurus maculatus) and Tasmanian devil (Sarcophilus harrisii).

Oecologia·2026
Same author

Docynia delavayi fruit polysaccharides alleviate DSS-induced ulcerative colitis via oxidative stress suppression in Drosophila model.

Scientific reports·2026
Same author

Digital Physiotherapeutic Elbow-Specific Training System for Patients After Arthroscopic Release of Elbow Contracture: Noninferiority Randomized Controlled Trial.

JMIR mHealth and uHealth·2026
Same author

miR156-StSPL9 regulating the biosynthesis of flavonoids and secondary metabolites in potato tubers.

BMC plant biology·2026
Same author

Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SAR.

Journal of medicinal chemistry·2026

関連する実験動画

Updated: Dec 11, 2025

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.4K

抗腫瘍活性を持つ経口利用可能な非ヌクレオチドSTINGアゴニスト

Bo-Sheng Pan1, Samanthi A Perera2, Jennifer A Piesvaux1

  • 1Department of Quantitative Biosciences, Merck & Co., Inc., Kenilworth, NJ, USA.

Science (New York, N.Y.)
|August 22, 2020
PubMed
まとめ

研究者らはMSA-2を発見しました これは先天的な免疫経路を活性化する 経口のSTINGアゴニストです この薬はマウスモデルで腫瘍の収縮,永続的な免疫,および抗PD-1療法との相乗効果を示し,有望ながん治療を提供しました.

さらに関連する動画

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.8K
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

2.2K

関連する実験動画

Last Updated: Dec 11, 2025

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.4K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.8K
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

2.2K

科学分野:

  • 免疫学
  • 薬理学について
  • 腫瘍学

背景:

  • STING (インターフェロン遺伝子の刺激器) 経路は,がんの免疫療法における重要な標的である.
  • 経口投与可能なSTINGアゴニストの開発は 効果的ながん治療に不可欠です

研究 の 目的:

  • ヒトのSTINGアゴニストであるMSA-2を特定し,特徴づけること.
  • 臨床前がんモデルにおけるMSA-2の治療の可能性を評価する.

主な方法:

  • MSA-2の識別と合成
  • マウスの共生性腫瘍モデルを用いた in vivo 研究
  • STINGの活性化メカニズム (モノメール-ダイマー均衡) の分析
  • 抗PD-1療法との相乗効果の評価

主要な成果:

  • MSA-2はよく耐受され,腫瘍におけるインターフェロン-βの分泌を刺激する.
  • MSA-2の経口および皮下投与は,腫瘍の回帰と持続的な抗腫瘍免疫を誘発した.
  • MSA-2は,抗PD-1療法と併用されたとき,相乗効果を示した.
  • MSA-2によるSTINGの活性化には,腫瘍の微小環境を模倣する細胞外酸化によって強化されたダイマー形成が必要です.

結論:

  • MSA-2は,好ましい安全性プロファイルを持つ強力で口服可能なSTINGアゴニストです.
  • 独特の作用メカニズムは,二重体形成に依存し,腫瘍の微小環境条件によって強化され,その治療効果を支えています.
  • MSA-2は全身がん免疫療法,特に併用療法において有望な候補である.